TNFRSF11A and breast cancer: However, MDA-MB-231-RANK-c cells seem to produce colonies of reduced size compared to control cells when treated with erlotinib or gefitinib, indicating that both agents in conjunction with RANK-c expression can reduce colony proliferation, but not the number of colony-initiating cells in the starting population of breast cancer cells (Figure 2C).